Coming August 2008.

The Ligand Binding Assay (LBA) Laboratory is a new addition to CEDRA Corporation, which complements our small molecule bioanalysis, pharmacokinetic modeling, and clinical trial management services. Upon implementation of all regulatory requirements (August 2008), the CEDRA LBA laboratory will provide bioanalytical services utilizing ligand binding methodologies to support regulated preclinical and clinical studies, including:

For inquiries, please contact William Nowatzke at 512.615.2258 or email at wnowatzke@cedracorp.com